You are here
Clinical Trials: Neuromuscular Disease
Each Clinical Trial will open in a new browser window or tab.
Condition: ALS (Amyotrophic Lateral Sclerosis)
Interventions: Drug: MNC (Mononuclear cells); Drug: Placebo / Saline
Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Not yet recruiting
Interventions: Drug: MNC (Mononuclear cells); Drug: Placebo / Saline
Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Not yet recruiting
Condition: Amyotrophic Lateral Sclerosis
Interventions: Biological: Lenzumestrocel; Drug: Riluzole
Sponsor: Corestem, Inc.
Recruiting
Interventions: Biological: Lenzumestrocel; Drug: Riluzole
Sponsor: Corestem, Inc.
Recruiting
Conditions: Polymyositis; Dermatomyositis
Intervention: Drug: MESENCHYMAL STROMAL CELLS (MSC's)
Sponsor: University of Florida
Not yet recruiting
Intervention: Drug: MESENCHYMAL STROMAL CELLS (MSC's)
Sponsor: University of Florida
Not yet recruiting
Condition: Brachial Plexus Neuropathies
Interventions: Procedure: Nerve transfer procedure; Procedure: Nerve transfer with HAM-AdMSC composite wrapping
Sponsor: Dr. Soetomo General Hospital
Recruiting
Interventions: Procedure: Nerve transfer procedure; Procedure: Nerve transfer with HAM-AdMSC composite wrapping
Sponsor: Dr. Soetomo General Hospital
Recruiting
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Mesenchymal stem cells isolated from Wharton's jelly
Sponsors: Polski Bank Komorek Macierzystych JSC (PBKM); The National Centre for Research and Development
Recruiting
Intervention: Drug: Mesenchymal stem cells isolated from Wharton's jelly
Sponsors: Polski Bank Komorek Macierzystych JSC (PBKM); The National Centre for Research and Development
Recruiting
Conditions: Myositis; Dermatomyositis; Polymyositis; Immune-Mediated Necrotizing Myopathy
Intervention: Other: High-intensity strength training
Sponsors: Rigshospitalet, Denmark; University of Southern Denmark; Odense University Hospital
Not yet recruiting
Intervention: Other: High-intensity strength training
Sponsors: Rigshospitalet, Denmark; University of Southern Denmark; Odense University Hospital
Not yet recruiting
Condition: Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Interventions: Drug: Memantine Hydrochloride Oral Solution; Drug: Trazodone Hydrochloride oral solution; Drug: Placebo oral solution
Sponsors: University of Edinburgh; University College, London; University of Warwick; NHS Lothian
Recruiting
Interventions: Drug: Memantine Hydrochloride Oral Solution; Drug: Trazodone Hydrochloride oral solution; Drug: Placebo oral solution
Sponsors: University of Edinburgh; University College, London; University of Warwick; NHS Lothian
Recruiting
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: RAPA-501 Autologous T cells
Sponsors: Rapa Therapeutics LLC; Massachusetts General Hospital; Hackensack Meridian Health
Not yet recruiting
Intervention: Biological: RAPA-501 Autologous T cells
Sponsors: Rapa Therapeutics LLC; Massachusetts General Hospital; Hackensack Meridian Health
Not yet recruiting
Condition: Neuralgia
Intervention: Other: Exosomes
Sponsor: Neurological Associates of West Los Angeles
Recruiting
Intervention: Other: Exosomes
Sponsor: Neurological Associates of West Los Angeles
Recruiting
Condition: Peripheral Nerve Injury Upper Limb
Intervention: Procedure: Avance Nerve Graft with Autologous BMAC
Sponsors: Brooke Army Medical Center; Walter Reed National Military Medical Center; Curtis National Hand Center at MedStar Union Memorial Hospital; Cleveland Clinic Lerner Research Institute
Recruiting
Intervention: Procedure: Avance Nerve Graft with Autologous BMAC
Sponsors: Brooke Army Medical Center; Walter Reed National Military Medical Center; Curtis National Hand Center at MedStar Union Memorial Hospital; Cleveland Clinic Lerner Research Institute
Recruiting
2023 AlphaMed Press ©